Industry Analysis & Industry Trends
In the past five years, the global recession tempered demand for nonessential health products and reduced funding for biotechnology research and development from private investors. Despite these factors, industry firms thrived on the back of technological advances that facilitated new discoveries and stimulated greater demand from firms in the pharmaceuticals and agricultural sectors. Industry growth is forecast to continue skyrocketing in the next five-year period as investment in biotechnology from around the world increases, particularly from emerging economies... read more
Industry Key Buyers
The Global Biotechnology industry continues to be populated by many small companies, alongside a few giant pharmaceutical, chemical and agricultural firms. IBISWorld estimates that the top four industry players will account for 28.9% of the industry's revenue in 2014, representing a low level of market share concentration. According to a 2012 Key Biotechnology Indicators Report by the Organisation for Economic Co-Operation and Development (latest available data), the majority of firms have fewer than 50 employees, and the share of firms with fewer than 50 employees ranges from 44.4% in Japan to 91.1% in New Zealand.
Because companies specialize in certain diseases or products that are not transferable across other industry segments, concentration tends to stay low... read more